Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Growth (Status and Outlook) 2021-2026


Jul, 2021 | Report ID: 193252 | 108 | Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs will have significant change from previous year. By the most conservative estimates of global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Filgrastim

Pefigrastim

Lipefigrastim

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Oncology

Blood Disease

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Amgen

Kyowa Kirin

Chugai Pharmaceutical

Novartis

Teva

Pfizer

Merck

Dong-A Socio

Intas

GenSci

Dr. Reddy

Amoytop

North China Pharmaceutical

SL Pharm

Hayao Group


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2016-2026

2.1.2 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Segment by Type

2.2.1 Filgrastim

2.2.2 Filgrastim

2.2.3 Lipefigrastim

2.3 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type

2.3.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size CAGR by Type

2.3.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type (2016-2021)

2.4 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Segment by Application

2.4.1 Oncology

2.4.2 Blood Disease

2.4.3 Other

2.5 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application

2.5.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size CAGR by Application

2.5.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application (2016-2021)

3 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Players

3.1 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Players

3.1.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue by Players (2019-2021E)

3.1.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Players (2019-2021E)

3.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs by Regions

4.1 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Regions (2016-2021)

4.2 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth (2016-2021)

4.3 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth (2016-2021)

4.4 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth (2016-2021)

4.5 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth (2016-2021)

5 Americas

5.1 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021)

5.2 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021)

5.3 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Region (2016-2021)

6.2 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021)

6.3 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs by Country (2016-2021)

7.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021)

7.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs by Region (2016-2021)

8.2 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021)

8.3 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecast by Regions (2021-2026)

10.1.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecast by Regions (2021-2026)

10.1.2 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecast

10.1.3 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecast

10.1.4 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecast

10.1.5 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecast

10.2 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecast by Countries (2021-2026)

10.2.1 United States Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.2.2 Canada Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.2.3 Mexico Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.2.4 Brazil Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.3 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecast by Region (2021-2026)

10.3.1 China Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.3.2 Japan Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.3.3 Korea Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.3.4 Southeast Asia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.3.5 India Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.3.6 Australia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.4 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecast by Country (2021-2026)

10.4.1 Germany Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.4.2 France Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.4.3 UK Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.4.4 Italy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.4.5 Russia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.5 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecast by Region (2021-2026)

10.5.1 Egypt Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.5.2 South Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.5.3 Israel Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.5.4 Turkey Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.5.5 GCC Countries Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Forecast

10.6 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecast by Type (2021-2026)

10.7 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Amgen

11.1.1 Amgen Company Information

11.1.2 Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

11.1.3 Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Amgen Main Business Overview

11.1.5 Amgen Latest Developments

11.2 Kyowa Kirin

11.2.1 Kyowa Kirin Company Information

11.2.2 Kyowa Kirin Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

11.2.3 Kyowa Kirin Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Kyowa Kirin Main Business Overview

11.2.5 Kyowa Kirin Latest Developments

11.3 Chugai Pharmaceutical

11.3.1 Chugai Pharmaceutical Company Information

11.3.2 Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

11.3.3 Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Chugai Pharmaceutical Main Business Overview

11.3.5 Chugai Pharmaceutical Latest Developments

11.4 Novartis

11.4.1 Novartis Company Information

11.4.2 Novartis Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

11.4.3 Novartis Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Novartis Main Business Overview

11.4.5 Novartis Latest Developments

11.5 Teva

11.5.1 Teva Company Information

11.5.2 Teva Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

11.5.3 Teva Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Teva Main Business Overview

11.5.5 Teva Latest Developments

11.6 Pfizer

11.6.1 Pfizer Company Information

11.6.2 Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

11.6.3 Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Pfizer Main Business Overview

11.6.5 Pfizer Latest Developments

11.7 Merck

11.7.1 Merck Company Information

11.7.2 Merck Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

11.7.3 Merck Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Merck Main Business Overview

11.7.5 Merck Latest Developments

11.8 Dong-A Socio

11.8.1 Dong-A Socio Company Information

11.8.2 Dong-A Socio Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

11.8.3 Dong-A Socio Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Dong-A Socio Main Business Overview

11.8.5 Dong-A Socio Latest Developments

11.9 Intas

11.9.1 Intas Company Information

11.9.2 Intas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

11.9.3 Intas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Intas Main Business Overview

11.9.5 Intas Latest Developments

11.10 GenSci

11.10.1 GenSci Company Information

11.10.2 GenSci Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

11.10.3 GenSci Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 GenSci Main Business Overview

11.10.5 GenSci Latest Developments

11. Dr. Reddy

11.11.1 Dr. Reddy Company Information

11.11.2 Dr. Reddy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

11.11.3 Dr. Reddy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Dr. Reddy Main Business Overview

11.11.5 Dr. Reddy Latest Developments

11.12 Amoytop

11.12.1 Amoytop Company Information

11.12.2 Amoytop Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

11.12.3 Amoytop Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 Amoytop Main Business Overview

11.12.5 Amoytop Latest Developments

11.13 North China Pharmaceutical

11.13.1 North China Pharmaceutical Company Information

11.13.2 North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

11.13.3 North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.13.4 North China Pharmaceutical Main Business Overview

11.13.5 North China Pharmaceutical Latest Developments

11.14 SL Pharm

11.14.1 SL Pharm Company Information

11.14.2 SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

11.14.3 SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.14.4 SL Pharm Main Business Overview

11.14.5 SL Pharm Latest Developments

11.15 Hayao Group

11.15.1 Hayao Group Company Information

11.15.2 Hayao Group Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

11.15.3 Hayao Group Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.15.4 Hayao Group Main Business Overview

11.15.5 Hayao Group Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Filgrastim

Table 3. Major Players of Pefigrastim

Table 4. Major Players of Lipefigrastim

Table 5. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 6. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 7. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type (2016-2021)

Table 8. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 9. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 10. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application (2016-2021)

Table 11. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue by Players (2019-2021E) & ($ Millions)

Table 12. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Players (2019-2021E)

Table 13. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Key Players Head office and Products Offered

Table 14. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Regions 2016-2021 & ($ Millions)

Table 18. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Regions 2016-2021

Table 19. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021) & ($ Millions)

Table 20. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Country (2016-2021)

Table 21. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 22. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type (2016-2021)

Table 23. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 24. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application (2016-2021)

Table 25. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Region (2016-2021) & ($ Millions)

Table 26. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Region (2016-2021)

Table 27. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 28. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type (2016-2021)

Table 29. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 30. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application (2016-2021)

Table 31. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021) & ($ Millions)

Table 32. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Country (2016-2021)

Table 33. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 34. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type (2016-2021)

Table 35. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 36. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application (2016-2021)

Table 37. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Region (2016-2021) & ($ Millions)

Table 38. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Region (2016-2021)

Table 39. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 40. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type (2016-2021)

Table 41. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 42. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application (2016-2021)

Table 43. Key and Potential Regions of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs

Table 44. Key Application and Potential Industries of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs

Table 45. Key Challenges of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs

Table 46. Key Trends of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs

Table 47. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 48. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share Forecast by Regions (2021-2026)

Table 49. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 50. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share Forecast by Type (2021-2026)

Table 51. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 52. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share Forecast by Application (2021-2026)

Table 53. Amgen Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors

Table 54. Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

Table 55. Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 56. Amgen Main Business

Table 57. Amgen Latest Developments

Table 58. Kyowa Kirin Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors

Table 59. Kyowa Kirin Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

Table 60. Kyowa Kirin Main Business

Table 61. Kyowa Kirin Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 62. Kyowa Kirin Latest Developments

Table 63. Chugai Pharmaceutical Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors

Table 64. Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

Table 65. Chugai Pharmaceutical Main Business

Table 66. Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 67. Chugai Pharmaceutical Latest Developments

Table 68. Novartis Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors

Table 69. Novartis Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

Table 70. Novartis Main Business

Table 71. Novartis Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 72. Novartis Latest Developments

Table 73. Teva Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors

Table 74. Teva Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

Table 75. Teva Main Business

Table 76. Teva Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 77. Teva Latest Developments

Table 78. Pfizer Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors

Table 79. Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

Table 80. Pfizer Main Business

Table 81. Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 82. Pfizer Latest Developments

Table 83. Merck Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors

Table 84. Merck Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

Table 85. Merck Main Business

Table 86. Merck Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 87. Merck Latest Developments

Table 88. Dong-A Socio Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors

Table 89. Dong-A Socio Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

Table 90. Dong-A Socio Main Business

Table 91. Dong-A Socio Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 92. Dong-A Socio Latest Developments

Table 93. Intas Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors

Table 94. Intas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

Table 95. Intas Main Business

Table 96. Intas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 97. Intas Latest Developments

Table 98. GenSci Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors

Table 99. GenSci Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

Table 100. GenSci Main Business

Table 101. GenSci Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 102. GenSci Latest Developments

Table 103. Dr. Reddy Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors

Table 104. Dr. Reddy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

Table 105. Dr. Reddy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 106. Dr. Reddy Main Business

Table 107. Dr. Reddy Latest Developments

Table 108. Amoytop Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors

Table 109. Amoytop Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

Table 110. Amoytop Main Business

Table 111. Amoytop Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 112. Amoytop Latest Developments

Table 113. North China Pharmaceutical Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors

Table 114. North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

Table 115. North China Pharmaceutical Main Business

Table 116. North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 117. North China Pharmaceutical Latest Developments

Table 118. SL Pharm Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors

Table 119. SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

Table 120. SL Pharm Main Business

Table 121. SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 122. SL Pharm Latest Developments

Table 123. Hayao Group Details, Company Type, Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Area Served and Its Competitors

Table 124. Hayao Group Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Offered

Table 125. Hayao Group Main Business

Table 126. Hayao Group Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 127. Hayao Group Latest Developments

List of Figures

Figure 1. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type in 2020

Figure 7. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs in Oncology

Figure 8. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market: Oncology (2016-2021) & ($ Millions)

Figure 9. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs in Blood Disease

Figure 10. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market: Blood Disease (2016-2021) & ($ Millions)

Figure 11. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs in Other

Figure 12. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market: Other (2016-2021) & ($ Millions)

Figure 13. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application in 2020

Figure 14. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Player in 2020

Figure 15. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Regions (2016-2021)

Figure 16. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2016-2021 ($ Millions)

Figure 17. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2016-2021 ($ Millions)

Figure 18. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2016-2021 ($ Millions)

Figure 19. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2016-2021 ($ Millions)

Figure 20. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Country in 2020

Figure 21. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type in 2020

Figure 22. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application in 2020

Figure 23. United States Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 24. Canada Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 25. Mexico Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 26. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Regions in 2020

Figure 27. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type in 2020

Figure 28. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application in 2020

Figure 29. China Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 30. Japan Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 31. Korea Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 32. Southeast Asia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 33. India Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 34. Australia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 35. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Country in 2020

Figure 36. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type in 2020

Figure 37. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application in 2020

Figure 38. Germany Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 39. France Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 40. UK Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 41. Italy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 42. Russia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 43. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Region in 2020

Figure 44. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Type in 2020

Figure 45. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Market Share by Application in 2020

Figure 46. Egypt Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 47. South Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 48. Israel Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 49. Turkey Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 50. GCC Country Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 51. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 52. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 53. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 54. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 55. United States Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 56. Canada Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 57. Mexico Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 58. Brazil Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 59. China Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 60. Japan Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 61. Korea Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 62. Southeast Asia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 63. India Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 64. Australia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 65. Germany Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 66. France Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 67. UK Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 68. Italy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 69. Russia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 70. Spain Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 71. Egypt Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 72. South Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 73. Israel Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 74. Turkey Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Figure 75. GCC Country Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size 2021-2026 ($ Millions)

Sample Request is not available